Brenipatide or placebo added to usual care for adults with schizophrenia
About this title
Read the official source — NCT07410507This study evaluates the safety and effectiveness of Brenipatide for people with schizophrenia.
Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Recruiting now refers to the overall study. Local openings are shown only when the registry lists an open site.
This study evaluates the safety and effectiveness of Brenipatide for people with schizophrenia.
A Study of Brenipatide in Participants With Opioid Use Disorder
Read the official source — NCT07420283A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study With a Separate Open-label Cohort to Evaluate the Efficacy and Safety of Brenipatide as Adjunctive Treatment to Transmucosal Buprenorphine With or Without Naloxone in Early Recovery of Participants With Opioid Use Disorder (RENEW-Op-1)
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Read the official source — NCT07219966A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Alcohol Use Disorder (RENEW-ALC-1)
Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors
A Randomized, Placebo Controlled Study of Cannabidiol in Young Adult Cannabis Users
A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Researchers are comparing NTX-1472 and placebo, tracking side effects to assess safety and tolerability in adults with an anxiety condition.
This study evaluates the safety and effectiveness of Seltorexant for people with depression.
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
Read the official source — NCT06655883Researchers are comparing Suvorexant and placebo, tracking side effects to assess safety in people with opioid dependence.
A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder
Read the official source — NCT05664516A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Intranasal Oxytocin in Adults With Binge-eating Disorder
This study evaluates the safety of Aticaprant for people with schizophrenia.
Using Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.